IABP-SHOCK II
Intra-Aortic Balloon Pump in Cardiogenic Shock
Paziente / Popolazione Intervento / Esposizione Confronto Esito
In 600 patients with MI-related cardiogenic shock undergoing revascularisation, intra-aortic balloon counterpulsation did not reduce 30-day mortality versus no IABP.
N
600
Disegno
Multicentre RCT, Germany
Esito
30-day all-cause mortality
Rilevanza
1
Risultato39.7% vs 41.3% (RR 0.96; p=0.69). Persistent null at 1, 6 and 12 y.
Thiele H, et al. N Engl J Med. 2012;367(14):1287-1296. 10.1056/NEJMoa1208410
Discussione e critica
Retired routine IABP; guidelines downgraded to Class IIIa.